ARTICLE | Company News
Nuron, Vitruvian Biomedical deal
April 16, 2012 7:00 AM UTC
Vitruvian granted Nuron exclusive, worldwide rights to develop and commercialize Vitruvian's AB42 vaccine, a DNA vaccine containing a gene fragment that codes for beta amyloid 42. The vaccine is in ...